71.09
3.30%
2.37
Bio Techne Corp (TECH) 最新ニュース
Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Brown Capital Management LLC - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Natixis Advisors LLC - MarketBeat
Thrivent Financial for Lutherans Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne (STU:TE1) Enterprise Value : €10,153 Mil (As of Nov. 20, 2024) - GuruFocus.com
Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? - MSN
Bio-Techne To Present At Stephens NASH 2024 Conference; Webcast At 12:00 PM ET - Nasdaq
Bio-Techne partners with Leader Life Sciences in GCC - Investing.com
Segall Bryant & Hamill LLC Has $38.20 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES - Yahoo Finance
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH - Quantisnow
Broadcrest Asset Management LLC Has $15.99 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Royce & Associates LP Acquires 17,296 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO - Quantisnow
Geneva Capital Management LLC Has $88.27 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET - Nasdaq
Bio-Techne (NASDAQ:TECH) Raised to Buy at StockNews.com - MarketBeat
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - Marketscreener.com
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) is Montanaro Asset Management Ltd's 3rd Largest Position - MarketBeat
Ownership Capital B.V. Sells 208,493 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
When the Price of (TECH) Talks, People Listen - Stock Traders Daily
Bio-Techne Corporation: An Insight Into Its Market Position & Product Expansion in Diagnostics and Spatial Biology!Major Drivers - Smartkarma
Asset Management One Co. Ltd. Has $9.69 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Van ECK Associates Corp - MarketBeat
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance
Ex-Dividend Reminder: Bio-Techne, Pfizer and Tompkins Financial - Nasdaq
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING - WV News
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - Yahoo Finance
Bio-Techne (FRA:TE1) Change In Receivables : €-33 Mil (TTM As of Sep. 2024) - GuruFocus.com
Bio-Techne Corporation (TECH) Announces Executive Compensation U - GuruFocus.com
Bio-Techne awards CFO restricted stock units for retention - Investing.com
TECH (Bio-Techne) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH - Quantisnow
Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket - MSN
Bio-Techne Corp (TECH)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus.com
New York State Common Retirement Fund Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) Upgraded to Buy at StockNews.com - MarketBeat
9 Best Biotech Stocks Of November 2024 - Forbes
Bio-Techne Corporation (NASDAQ:TECH) Q1 2025 Earnings Call Transcript - Insider Monkey
TECH (Bio-Techne) Total Inventories : $185 Mil (As of Sep. 2024) - GuruFocus.com
Bio-Techne Tops Profit Forecasts Thanks To Booming Diagnostics - Finimize
Bio-Techne shares target raised, outperform on strong Q1 results By Investing.com - Investing.com Australia
Earnings call: Bio-Techne reports steady growth in Q1 FY2025 - Investing.com
Earnings call: Bio-Techne reports steady growth in Q1 FY2025 By Investing.com - Investing.com UK
Bio-Techne shares target raised, outperform on strong Q1 results - Investing.com India
Robert W. Baird Forecasts Strong Price Appreciation for Bio-Techne (NASDAQ:TECH) Stock - MarketBeat
Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigat - GuruFocus.com
Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... - Yahoo Finance
Bio-Techne holds at $80 target with Overweight rating - Investing.com India
Bio-Techne holds at $80 target with Overweight rating By Investing.com - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):